Prevention and Management of Common Adverse Effects of Ketamine and Esketamine in Patients with Mood Disorders

Ceban, F; Rosenblat, JD; Kratiuk, K; Lee, Y; Rodrigues, NB; Gill, H; Subramaniapillai, M; Nasri, F; Lui, LMW; Lipsitz, O; Kumar, A; Lee, JG; Chau, EH; Cao, B; Lin, K; Ho, RC; Mansur, RB; Swainson, J; McIntyre, RS

McIntyre, RS (corresponding author), Univ Hlth Network, Poul Hansen Family Ctr Depress, Mood Disorders Psychopharmacol Unit, 399 Bathurst St,MP 9-325, Bathurst, ON M5T 2S8, Canada.; McIntyre, RS (corresponding author), Braxia Hlth, Mississauga, ON, Canada.; McIntyre, RS (corresponding author), Univ Toronto, Dept Psychiat, Toronto, ON, Canada.; McIntyre, RS (corresponding author), Univ Toronto, Dept Pharmacol, Toronto, ON, Canada.

CNS DRUGS, 2021; 35 (9): 925

Abstract

The emerging roles of ketamine and esketamine as effective rapid-acting antidepressants hold promise for patients suffering from treatment-resistant d......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索